Gateway news 1 (03-12-2002)

This Gateway news replaces the previous one: an error in the calculation of the scores was detected. This error has been corrected.

So the first positive result of this news was to detect this error!

So this page is presenting new results related to the scores given by partners to your site descriptions.

The second good news is that now the partners' way to score the sites is much more balanced.

Introduction

Today, our Gateway presents 171 described websites (no counting doubloons).

- 56 from Drugscope

- 28 from Toxibase

- 27 from Gruppo Abele

- 21 from Archido

- 15 from Trimbos

- 8 from PND

- 5 from CAN

- 5 from CZU

- 5 from Ektpen (Elisad member)

- 1 from IPDT (Elisad member)

The scores

Today, 3rd December 2003, 4 websites have got 100

The winners are:

- Drugscope

- Unicri

- GEA 2000

- Fuoriluogo

Just behind are:

- Ginko e.V. (95)

- Osservatorio permanente sui giovani e alcool (94) (although I wonder how a difference from 94 to 95 is possible in the calculation process...)

- EMCDDA (90)

- Inpes (90)

- Supro (90)

- O ci sei o ti fai (90)

To resume:

10 sites have got from 90 to 100

27 sites have got from 80 to 89

28 sites have fot from 70 to 79

48 sites have got from 60 to 69

32 sites have got from 50 to 59

17 sites have got from 40 to 49

5 sites have got from 30 to 39

4 sites have got under 30

The biggest number of sites have got from 60 to 69: quite normal!

145 on 171 websites (85%) got 50 or more!

Only 26 sites got less than 50

The loosers are (30 or less):

- Villa Maraini (30)

- 18 ANO (30)

- Orexis (25),

- Cannabis.net (25)

- Parents Against Drug Abuse (20)

- CNID (10)

Among the 145 sites having more than 50:

- 26 sites on 27 (96,3%) evaluated by our Italian partner

- 20 sites on 21 (95,2%) evaluated by our German partner

- 49 sites on 56 (87,5%) evaluated by our UK partner

- 7 sites on 8 (87,5%) evaluated by our Spanish partner

- 23 site on 28 (82,1%) evaluated by our French partner

- 4 sites on 5 (80%) evaluated by our Swedish partner

- 10 sites on 15 (66,6%) evaluated by our Dutch partner

- 3 sites on 5 (60%) evaluated by our Czech partner

- 2 sites on 5 (40%) evaluated by Ektpen

- 1 site on 1 (100%) evaluated by IPDT

Questions:

What are the questions you would like to be overviewed by the GateNews 2?

Can this page be published in DrugLink and the Elisad journal?

And BRAVO for your work! Anne